Clinical Trials on Ovarian Cancer
Total 52910 results
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bosnia and Herzegovina, Bulgaria, Georgia, Korea, Republic of, Serbia
-
Yale UniversityNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IV Fallopian Tube Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Primary... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage I Ovarian Cancer AJCC v6 and v7 | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage II Ovarian Cancer AJCC v6 and v7 | Stage IIA Fallopian Tube Cancer AJCC v6 and v7 | Stage IIB Fallopian... and other conditionsUnited States
-
Radboud University Medical CenterRecruitingEpithelial Ovarian Cancer | Ovarian CarcinomaNetherlands
-
OncoResponse, Inc.RecruitingCancer | Metastatic Cancer | Advanced Solid Tumor | Platinum-resistant Ovarian Cancer | Malignant Neoplasm | Tumor, Solid | Cutaneous Squamous Cell CarcinomaUnited States
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
Grupo Español de Investigación en Cáncer de OvarioClovis Oncology, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
Craig L Slingluff, JrNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Geoff HallNational Health Service, United KingdomUnknownFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Gynaecological MalignancyUnited Kingdom
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
AltaRexUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerItaly, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedRelapsed Ovarian Cancers PatientsFrance
-
University of PennsylvaniaTheriva Biologics SLRecruitingPancreatic Cancer | Serous Ovarian CancerUnited States
-
Turku University HospitalRecruitingHypoxia | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CarcinomaFinland
-
Bristol-Myers SquibbCompletedPlatinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-lineUnited States
-
Krankenhaus Barmherzige Schwestern LinzWithdrawnFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustria
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
ImunonActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Canada
-
Shattuck Labs, Inc.Enrolling by invitationOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal CarcinomaUnited States, United Kingdom, Spain, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingStage IIIC Fallopian Tube Cancer | Stage IIIC Ovarian Cancer | Stage IIIC Primary Peritoneal Cancer | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal CancerUnited States
-
Leiden University Medical CenterRecruitingOvarian Cancer RecurrentNetherlands
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
Asan Medical CenterUnknownEpithelial Ovarian CancerKorea, Republic of
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
Instituto de Investigação em ImunologiaButantan InstituteUnknownCancer. | Melanoma. | Ovarian Cancer. | Lung Cancer.Brazil
-
EndocyteCompletedOvary CancerCanada, United States
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Syndax PharmaceuticalsPfizer; Merck KGaA, Darmstadt, GermanyCompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
ImunonCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
amy tierstenAstraZeneca; Eisai Inc.CompletedRecurrent Ovarian Cancer | HER2-Negative Metastatic Breast CancerUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Austria, Belgium, Italy, Netherlands, Spain, Canada, Denmark, Germany, Korea, Republic of, Russian Federation, Hong Kong, Greece, Japan
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
-
Imperial College LondonNot yet recruitingOvarian Neoplasms | Ovarian Cancer | Ovary Cancer | Germ Cell Tumor | Ovary Neoplasm | Germ Cell Cancer | Germ Cell Ovarian Cancer | Germ Cell Neoplasia
-
Charles University, Czech RepublicUniversity Hospital Ostrava; University Hospital Olomouc; University Hospital... and other collaboratorsRecruitingOvarian Cancer | Frailty | Endometrial Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage IIICzechia
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Robert EdwardsMerck Sharp & Dohme LLC; AIM ImmunoTech Inc.RecruitingOvarian Cancer RecurrentUnited States
-
ARCAGY/ GINECO GROUPActive, not recruitingEpithelial Ovarian Cancer | RelapseFrance
-
Ruhr University of BochumCompletedRecurrent Ovarian CancerGermany
-
University of Alabama at BirminghamNovartis PharmaceuticalsCompletedRecurrent Ovarian CancerUnited States
-
Samsung Medical CenterAstraZenecaCompletedTo Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer
-
Leiden University Medical CenterUniversity Medical Center GroningenCompleted
-
Shaare Zedek Medical CenterGina-Life Diagnostics ltd.Withdrawn